Processa Pharmaceuticals, Inc. (PCSA)
3.36
-0.10
(-2.89%)
USD |
NASDAQ |
Jan 09, 16:00
3.38
+0.02
(+0.60%)
After-Hours: 20:00
Processa Pharmaceuticals Shareholders Equity (Quarterly): 5.834M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | 23.69M |
| Pyxis Oncology, Inc. | 68.78M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.585M |
| Total Liabilities (Quarterly) | 1.751M |
| Current Ratio | 3.762 |
| Net Debt Paydown Yield | 0.23% |